Area of research
Hematology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Hemophilia Treatment and Research, Platelet Disorders and Treatments, Monoclonal and Polyclonal Antibodies Research, and T-cell and B-cell Immunology.
Tolerance to factor VIII in the era of nonfactor therapies: immunologic perspectives and a systematic review of the literature.
Patient anti-FVIII drug antibodies bind preferentially to a subset of FVIII covalent states.
[A new role for antibodies in deep venous thrombosis].
Efanesoctocog alfa: the renaissance of Factor VIII replacement therapy
Inhibitors-Recent insights.
IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies.
Emerging benefits of Fc fusion technology in the context of recombinant factor VIII replacement therapy.
A molecular jewel for hemophilia A treatment.
Pathogenic immune response to therapeutic factor VIII: exacerbated response or failed induction of tolerance?
Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium